Analysis of CXCR5+Th17 cells in relation to disease activity and TNF inhibitor therapy in Rheumatoid Arthritis
Open Access
- 22 December 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 39474
Abstract
Th17 and TfH cells are thought to promote tissue inflammation and autoantibody production, respectively, in autoimmune diseases including rheumatoid arthritis (RA). TfH cells that co-express Th17 markers (CXCR5+Th17) encompass both of these pathogenic functions, and are increased in some human autoimmune settings including juvenile dermatomyositis. We investigated CXCR5+Th17 cells in RA subjects with stable or active disease and before and after TNF inhibitor therapy. CXCR5+Th17 cell frequency was increased in RA compared to healthy controls, but other helper T cell subsets were not different. CXCR5+Th17 cells correlated with disease activity in subjects with active RA prior to initiation of TNF inhibitor therapy. Baseline CXCR5+Th17 cells also correlated with numbers of swollen joints as late as one year post-therapy. CXCR5+Th17 cell frequencies were unaltered by TNF blockade and in fact remained remarkably stable within individuals. We conclude that CXCR5+Th17 cells are not a direct target of TNF blockade and therefore cannot serve as a biomarker of current disease activity. However, basal CXCR5+Th17 cell frequency may indicate underlying differences in disease phenotype between patients and predict ultimate success of TNF inhibitor therapy.Keywords
This publication has 42 references indexed in Scilit:
- The Phenotype of Circulating Follicular-Helper T Cells in Patients with Rheumatoid Arthritis Defines CD200 as a Potential Therapeutic TargetJournal of Immunology Research, 2012
- Increased Frequency of Circulating Follicular Helper T Cells in Patients with Rheumatoid ArthritisJournal of Immunology Research, 2012
- Follicular Helper CD4 T Cells (TFH)Annual Review of Immunology, 2011
- Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody SecretionImmunity, 2011
- Preclinical Rheumatoid Arthritis: Identification, Evaluation, and Future Directions for InvestigationRheumatic Disease Clinics of North America, 2010
- The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cellsNature Immunology, 2008
- ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunityJournal of Experimental Medicine, 2008
- From interleukin‐23 to T‐helper 17 cells: human T‐helper cell differentiation revisitedImmunological Reviews, 2008
- Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal modelJournal of Experimental Medicine, 2007
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999